SCHEMBL26645356

SCHEMBL26645356

CC1c2c(-c3ccnc4[nH]ccc34)c(-c3ccc(C(F)(F)F)cc3)nn2CCN1C(=O)/C=C/CN(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRAF P15056 2/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ JAK3 P52333 5/20 0.38
▸ AURKB Q96GD4 4/20 0.36
▸ INCENP Q9NQS7 2/20 0.36
▸ AURKA O14965 3/20 0.35
▸ CCNK O75909 3/20 0.35
▸ CDK12 Q9NYV4 3/20 0.35
▸ JAK2 O60674 3/20 0.34
▸ JAK1 P23458 3/20 0.34
▸ CIT O14578 1/20 0.34
▸ CSNK1D P48730 2/20 0.33
▸ MAPK14 Q16539 2/20 0.33
▸ BTK Q06187 1/20 0.33
▸ MAPK11 Q15759 1/20 0.33
▸ LYN P07948 1/20 0.33
▸ IGF1R P08069 1/20 0.33
▸ MET P08581 1/20 0.33
▸ ROCK1 Q13464 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26644942 1.00 BRAF (0.38) BRAFCYP2D6CYP2C9JAK3AURKB
SCHEMBL30623112 1.00 BRAF (0.38) BRAFCYP2D6CYP2C9JAK3AURKB
SCHEMBL30622306 0.92 MAPK14 (0.42) JAK3AURKBINCENPAURKACCNK
SCHEMBL26645246 0.92 MAPK14 (0.42) JAK3AURKBINCENPAURKACCNK
SCHEMBL26645464 0.92 MAPK14 (0.42) JAK3AURKBINCENPAURKACCNK
SCHEMBL30622344 0.92 MAPK14 (0.42) JAK3AURKBINCENPAURKACCNK
SCHEMBL26644987 0.88 BRAF (0.40) BRAFCYP2D6CYP2C9JAK3AURKB
SCHEMBL30622417 0.88 BRAF (0.40) BRAFCYP2D6CYP2C9JAK3AURKB
SCHEMBL30622885 0.88 BTK (0.33) CYP2D6CYP2C9JAK3CCNKCDK12
SCHEMBL30622963 0.88 BTK (0.33) CYP2D6CYP2C9JAK3CCNKCDK12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023213882-A1 IRREVERSIBLE MUTEGFR INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2023-11-09 — — WO disclosed
Send feedback